KL and arteriosclerosis: Targeting the FGF-Klotho endocrine axis plays a critical role in the pathophysiology of aging-related diseases, such as diabetes, cancer, arteriosclerosis, and chronic kidney disease (16), some of which are associated with obesity (e.g., arteriosclerosis, diabetes, osteoporosis) (17, 18).